Workflow
创新医疗(002173)9月22日主力资金净卖出1.75亿元

Core Viewpoint - The stock of Innovation Medical (002173) has experienced a decline, with significant net outflows from major funds, while retail investors have shown a net inflow [1][2]. Group 1: Stock Performance - As of September 22, 2025, Innovation Medical closed at 21.53 yuan, down 4.18% with a turnover rate of 14.72% and a trading volume of 612,900 hands, resulting in a transaction amount of 1.34 billion yuan [1]. - Over the past five days, the stock has seen a consistent decline, with the highest drop recorded on September 18 at 4.75% [2]. Group 2: Fund Flow Analysis - On September 22, 2025, major funds had a net outflow of 175 million yuan, accounting for 13.08% of the total transaction amount, while retail investors had a net inflow of 196 million yuan, representing 14.64% of the total [1][2]. - The trend over the past five days shows a pattern of net outflows from major and speculative funds, with retail investors consistently showing net inflows [2]. Group 3: Company Financials - Innovation Medical reported a total market value of 9.501 billion yuan, with a net asset value of 1.766 billion yuan and a net profit of -11.3613 million yuan, indicating a poor financial standing compared to the industry averages [3]. - The company's gross margin stands at 12.06%, significantly lower than the industry average of 35.92%, and the net profit margin is -2.79% compared to the industry average of 3.8% [3]. - For the first half of 2025, the company’s main revenue was 402 million yuan, a year-on-year decrease of 1.6%, while the net profit attributable to shareholders was -11.3613 million yuan, a year-on-year increase of 29.12% [3].